Deficiencies Common In Radiation Therapy Trial Reports For Hodgkin's, Non-Hodgkin's Lymphoma

Reporting of radiation therapy details in randomized controlled trials for Hodgkin's and non-Hodgkin's lymphoma is deficient due to a lack of reporting of key radiation therapy descriptors and quality assurance processes designed to ensure the accuracy and reproducibility of treatment regimens, according to a February 1 study in the International Journal of Radiation Oncology*Biology* Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

Randomized controlled trial reports are the primary source of trial documentation that is available to clinicians and patients, and complete descriptions of the therapies used are necessary for proper interpretation and replication of the trials.

source: American Society for Radiation Oncology